# Tirofiban in Stenting for Long Coronary Lesion

> **NCT01498003** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 748 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** tirofiban
- **DRUG:** normal saline solution

## Key facts

- **NCT ID:** NCT01498003
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 748 (ACTUAL)
- **Last updated:** 2015-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498003, "Tirofiban in Stenting for Long Coronary Lesion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01498003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*